Cargando…

Diagnostic value of fecal Fusobacterium nucleatum in colorectal cancer

Detalles Bibliográficos
Autores principales:	Xing, Chen, Zhihao, Li, Ji, Di
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696960/ http://dx.doi.org/10.5114/aoms/174261

Ejemplares similares

Fusobacterium nucleatum and Colorectal Cancer
por: Li, Rongrong, et al.
Publicado: (2022)

Fusobacterium nucleatum-positive colorectal cancer
por: Yang, Zhenhua, et al.
Publicado: (2019)

The Role of Fecal Fusobacterium nucleatum and pks(+) Escherichia coli as Early Diagnostic Markers of Colorectal Cancer
por: Liu, Kaixi, et al.
Publicado: (2021)

Fusobacterium nucleatum infection correlates with two types of microsatellite alterations in colorectal cancer and triggers DNA damage
por: Okita, Yoshiki, et al.
Publicado: (2020)

Fusobacterium nucleatum: caution with interpreting historical patient sample cohort
por: Johnstone, Kate L. F., et al.
Publicado: (2021)

Fusobacterium nucleatum and colorectal cancer: A review
por: Shang, Fu-Mei, et al.
Publicado: (2018)

Fusobacterium nucleatum and cancer
por: Alon‐Maimon, Tamar, et al.
Publicado: (2022)

Prognostic impact of the Fusobacterium nucleatum status in colorectal cancers
por: Chen, Yanglong, et al.
Publicado: (2019)

Fecal Fusobacterium nucleatum for the diagnosis of colorectal tumor: A systematic review and meta‐analysis
por: Zhang, Xinyu, et al.
Publicado: (2019)

Diagnostic Performance of Intestinal Fusobacterium nucleatum in Colorectal Cancer: A Meta-Analysis
por: Peng, Bo-Jian, et al.
Publicado: (2018)

Global Investigations of Fusobacterium nucleatum in Human Colorectal Cancer
por: Lee, Seul A., et al.
Publicado: (2019)

Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism
por: Ou, Suwen, et al.
Publicado: (2022)

The Role of Fusobacterium nucleatum in Oral and Colorectal Carcinogenesis
por: Pignatelli, Pamela, et al.
Publicado: (2023)

The role of Fusobacterium nucleatum in colorectal cancer: from carcinogenesis to clinical management
por: Sun, Chun-Hui, et al.
Publicado: (2019)

Detection of Fusobacterium nucleatum in Patients with Colitis-Associated Colorectal Cancer
por: Dregelies, Theresa, et al.
Publicado: (2023)

A New Comorbidity in Periodontitis: Fusobacterium nucleatum and Colorectal Cancer
por: Mesa, Francisco, et al.
Publicado: (2022)

Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum
por: Brennan, Caitlin A., et al.
Publicado: (2021)

The Role of Fusobacterium nucleatum in Colorectal Cancer Cell Proliferation and Migration
por: Wu, Zihong, et al.
Publicado: (2022)

COVID-19–Associated Fusobacterium nucleatum Bacteremia, Belgium
por: Wolff, Louis, et al.
Publicado: (2021)

Fusobacterium nucleatum dissemination by neutrophils
por: Ellett, Felix, et al.
Publicado: (2023)

Salivary Fusobacterium nucleatum serves as a potential biomarker for colorectal cancer
por: Zhang, Xin, et al.
Publicado: (2022)

Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer
por: Gao, Yaohui, et al.
Publicado: (2021)

Diagnostic accuracy of Fusobacterium nucleatum IgA and IgG ELISA test in colorectal cancer
por: Kurt, Melike, et al.
Publicado: (2021)

Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location
por: Mima, Kosuke, et al.
Publicado: (2016)

Association between Fusobacterium nucleatum and colorectal cancer: Progress and future directions
por: Zhang, Sheng, et al.
Publicado: (2018)

Targeting Programmed Fusobacterium nucleatum Fap2 for Colorectal Cancer Therapy
por: Ganesan, Kumar, et al.
Publicado: (2019)

L-fucose ameliorates the carcinogenic properties of Fusobacterium nucleatum in colorectal cancer
por: Duan, Caihan, et al.
Publicado: (2021)

Evaluation of antibody level against Fusobacterium nucleatum in the serological diagnosis of colorectal cancer
por: Wang, Hai-Fang, et al.
Publicado: (2016)

Clinical Significance of Fusobacterium nucleatum and Microsatellite Instability in Evaluating Colorectal Cancer Prognosis
por: Xie, Yanxuan, et al.
Publicado: (2022)

Correction To: Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer
por: Gao, Yaohui, et al.
Publicado: (2021)

Salivary Fusobacterium nucleatum serves as a potential diagnostic biomarker for gastric cancer
por: Chen, Wen-Dan, et al.
Publicado: (2022)

Comparative Genome Analysis of Fusobacterium nucleatum
por: Ang, Mia Yang, et al.
Publicado: (2016)

Fusobacterium Nucleatum Empyema: An Atypical Presentation
por: Barrera-López, Lucía, et al.
Publicado: (2020)

Emphysematous Cholecystitis Secondary to Fusobacterium nucleatum
por: Kunadia, Anuj, et al.
Publicado: (2021)

Fusobacterium nucleatum Accelerates the Progression of Colitis-Associated Colorectal Cancer by Promoting EMT
por: Yu, Mi Ra, et al.
Publicado: (2020)

Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients
por: Kunzmann, Andrew T., et al.
Publicado: (2019)

Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis
por: Sakamoto, Yuki, et al.
Publicado: (2021)

Involvement of Fusobacterium nucleatum in malignancies except for colorectal cancer: A literature review
por: He, Zhixing, et al.
Publicado: (2022)

Clinicopathological and prognostic significance of Fusobacterium nucleatum infection in colorectal cancer: a meta-analysis
por: Huangfu, Shu-chen, et al.
Publicado: (2021)

Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity
por: Komiya, Yasuhiko, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_url3v19na21e5oa2afb8ngd8os